IPO

With its IPO complete, Cambridge Acquisition Corp. enters a disciplined SPAC market with a clear focus on wellness, hemp, and psychedelic tech targets.

Belgian biotech Agomab Therapeutics secures $200 million in its Nasdaq debut, fueling its mission to develop therapies for debilitating fibrotic conditions.

As the AI coding market heats up, Cursor's strategic hire of Brian McCarthy signals a major push for enterprise dominance against rivals like GitHub Copilot.

Hagerty elevates its marketing team, hiring a new SVP from AT&T to build a 'bespoke' membership experience and deepen its bond with car enthusiasts.

The restaurant group's net income fell sharply as a legal battle over its NYC flagship intensifies, while it places a risky bet on a NJ casino license.

As Omada Health preps its 2025 results, all eyes are on whether its blend of tech, human coaching, and GLP-1 support can deliver sustainable profits.

Swvl's new healthcare mobility contract in Saudi Arabia marks a strategic shift to high-value enterprise deals. Can this move stabilize the firm?

With a promising spinal cord injury drug nearing late-stage trials, NervGen appoints interim leader Dr. Adam Rogers as permanent CEO to guide the breakthrough.

Semiconductor leader Astera Labs launches a new R&D hub in Israel, hiring top tech veterans to develop next-gen connectivity for the demanding AI era.

Backed by robust earnings and strategic acquisitions, Atmus Filtration's latest dividend signals strong financial health and a commitment to shareholder returns.

The Middle East healthcare giant posts record profits and a $163M dividend, fueled by aggressive international acquisitions and a major bet on AI technology.

Leading manufacturer GEVORKYAN is launching its first ESOP, a strategic move to retain key talent and drive growth in the competitive powder metallurgy market.

After a second bankruptcy filing in five years, the 25-year-old fashion chain is closing for good, sparking huge sales and questions about its collapse.

Key Mining Corp. is going public via a SPAC deal to fund a massive titanium project in Chile, betting on rising demand for critical minerals.

Cantor Fitzgerald launches its 15th SPAC, raising $115M. With the market rebounding, will this bet on tech and healthcare pay off for investors?

Forgent Power Solutions saw a strong NYSE debut, but with IPO funds paying back its PE owner, is this a growth story or a private equity cash-out?

The veteran SPAC sponsor closes an upsized IPO for its eighth fund, targeting industrial tech and energy transition with a unique warrant-free structure.

Pan-European exchange reports a strong start to 2026, fueled by a historic defense IPO and a dramatic spike in foreign exchange and metals trading.

Inspired Entertainment launches STRATA, a cloud-native platform set to disrupt the lottery industry with unprecedented scalability, security, and flexibility.

A small-cap food company plans a major NASDAQ leap, but its future hinges on a secret 'clean' technology. Can this ambitious, risky pivot succeed?